Kit for the Preparation of Technetium Tc99m Sestamibi (Lantheus Medical Imaging, Inc.)


Welcome to the PulseAid listing for the Kit for the Preparation of Technetium Tc99m Sestamibi drug offered from Lantheus Medical Imaging, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Lantheus Medical Imaging, Inc.
NON-PROPRIETARY NAME: TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE
SUBSTANCE NAME: TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1990-12-20
END MARKETING DATE: 0000-00-00


Kit for the Preparation of Technetium Tc99m Sestamibi HUMAN PRESCRIPTION DRUG Details:

Item DescriptionKit for the Preparation of Technetium Tc99m Sestamibi from Lantheus Medical Imaging, Inc.
LABELER NAME: Lantheus Medical Imaging, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 1(mg/mL)
START MARKETING DATE: 1990-12-20
END MARKETING DATE: 0000-00-00
PRODUCT ID: 11994-003_929031aa-1664-43e2-a951-a6bc5c27854b
PRODUCT NDC: 11994-003
APPLICATION NUMBER: NDA019785

Other TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AnazaoHealth CorporationSestamibi
Lantheus Medical Imaging, Inc.Cardiolite
MALLINCKRODT NUCLEAR MEDICINE LLCTechnetium Tc 99m Sestamibi